malondialdehyde has been researched along with Connective Tissue Disease, Mixed in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gejyo, F; In, H; Ito, S; Izumi, J; Kanazawa, M; Nakano, M; Ohno, T; Tanaka, H; Ueno, M; Wada, Y; Yahata, K | 1 |
1 other study(ies) available for malondialdehyde and Connective Tissue Disease, Mixed
| Article | Year |
|---|---|
Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report.
Topics: Antibodies, Antineutrophil Cytoplasmic; Arteriosclerosis; Aspirin; Autoantibodies; Cholesterol, LDL; Female; Granulomatosis with Polyangiitis; Humans; Lipid Peroxidation; Malondialdehyde; Middle Aged; Mixed Connective Tissue Disease; Myeloblastin; Prednisolone; Probucol; Serine Endopeptidases; Treatment Outcome; Valproic Acid | 2004 |